For Immediate Release:
Contact: Kelly Broadway, 202-808-8853
kbroadway@health-innovation.org
Washington, D.C. – The Health Innovation Alliance (HIA) today released its principles for the regulation of artificial intelligence (AI) in health care and life sciences. Unlike other organizations, HIA’s principles are intended to guide Congress and the Administration and are focused exclusively on the use of AI in health care.
“Congress and the Administration should be cautious in jumping to regulate technology it does not understand,” said Brett Meeks, Executive Director of the Health Innovation Alliance. “The Health Innovation Alliance worked with a broad group of stakeholders on principles for the regulation of AI in health care to find a balance that allows for innovation and protects patients and their information.”
The principles are concentrated on:
- Risk-based approach – Regulation of AI in health care should be proportionate to risk
- Transparency – Patients, users, and regulators of AI should have access to information about how the technology is being used, but not to proprietary information
- Privacy – Any use of health information by AI should be compliant with current laws and regulations, including HIPAA
- Responsibility – Developers and users of AI programs in health care should adopt and adhere to best practices and processes
- Equity – AI tools should mitigate bias and be available for all users, not just those who can afford it
“Government should support AI for health care, and HIA believes that at least one-third of federal spending for AI should be allocated to health care,” said Meeks. “We think at least $10 billion of the recommended $32 billion in annual non-defense funding for AI should be used to improve patient care and outcomes, accelerate medical research, and reduce the burden of administrative tasks for caregivers.”
Click here for the complete report on HIA’s AI principles in health care.